Drug Research
Humanetics receives US DoD funding for Covid-19 drug development
Humanetics has received funding from the US Department of Defense (DoD) to carry out a series of studies with its novel drug candidate, BIO 300,...
Drug Research
X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend...
X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based sister...
Drug Research
BioMed X Institute starts new research project in drug...
German independent research institute BioMed X announces its new research project with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson...
Drug Research
Enara and Boehringer Ingelheim sign oncology partnership
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve the...
Drug Research
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located...
Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and...
Drug Research
Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer
Eli Lilly’s oncology-focused Loxo Oncology at Lilly will partner with Merus to develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies, through a research...
Drug Research
ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate...
ConserV Bioscience Limited (“ConserV”), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and Lawrence Livermore National Laboratory...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.